Meet our collaborative partners

We recognize the significant potential of our GalXC™ RNAi platform to identify potent and targeted medicines for a broad range of diseases. To realize its full potential, we are collaborating with some of the world’s leading biopharma companies to pair our RNAi knowledge and proprietary technology with our partners’ expertise and capabilities in specific therapeutic areas.